News

Empower Clinics Announces Closing of Second Tranche Private Placement Financing

VANCOUVER, BC / ACCESSWIRE / August 15, 2023 / Empower Clinics Inc. ("Empower" or the "Company") (CSE:EPW)(OTC PINK:EPWCF), is pleased…

1 year ago

Biotricity Reports Strong Growth for its First Quarter Fiscal Year 2024 and Provides Financial Results and Business Updates

REDWOOD CITY, CA / ACCESSWIRE / August 15, 2023 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a Technology-as-a-Service (TaaS)…

1 year ago

Vytalize Health Named No. 71 on Inc. 5000 List of America’s Fastest-Growing Companies

The company landed in the top 10 for Healthcare Services on Inc. Magazine's 2023 list following its remarkable growth and…

1 year ago

FSD Pharma Selected to Present its Phase 1 Data on Lucid-MS at MSMilan 2023 – 9th Joint ECTRIMS-ACTRIMS Meeting for October 11-13, 2023

Targeting the Approximate $22 Billion Multiple Sclerosis Drug Treatment MarketTORONTO, ON / ACCESSWIRE / August 15, 2023 / FSD Pharma…

1 year ago

National Eczema Association Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced

BOULDER, CO / ACCESSWIRE / August 15, 2023 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing…

1 year ago

Leading Provider of On-Demand Medical Equipment & Services for Hospitals, US Med-Equip, Secures Spot on Inc. 5000 Fastest-Growing Company List for the 11th Time

HOUSTON, TX / ACCESSWIRE / August 15, 2023 / US Med-Equip, a leading provider of on-demand medical equipment solutions, earned…

1 year ago

Fuse Medical, Inc. Announces Second Quarter 2023 Financial Results

RICHARDSON, Texas, Aug. 15, 2023 (GLOBE NEWSWIRE) -- On August 14, 2023, Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the…

1 year ago

Elevar Therapeutics Names Dr. Chris Galloway Vice President of Clinical Development

FORT LEE, N.J., Aug. 15, 2023 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. and…

1 year ago

NeurAxis Announces Positive University of Michigan IB-Stim™ Cost Effectiveness Study at ANMS 2023

CARMEL, Ind., Aug. 15, 2023 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (NYSE American: NRXS) (“NeurAxis” or the “Company”), a medical technology company…

1 year ago